Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on VESUVIUS PLC. We currently have 16 research reports from 1 professional analysts.
|23Mar17 11:20||RNS||Holding(s) in Company|
|23Mar17 07:00||RNS||Directorate Change|
|17Mar17 15:20||RNS||Director/PDMR Shareholding|
|13Mar17 11:43||RNS||Holding(s) in Company|
|07Mar17 14:53||RNS||Holding(s) in Company|
|03Mar17 10:49||RNS||Holding(s) in Company|
|02Mar17 07:00||RNS||Final Results|
Frequency of research reports
Research reports on
Panmure Morning Note 08-09-2016
08 Sep 16
QE is like Heineken, except it destroys things other stupid policies cannot reach. In the steel industry, it has the remarkable ability to encourage more capacity building while destroying demand. Since our downgrade to SELL on July 22, the fundamentals have deteriorated further with global steel capacity utilisation falling back to Q3/15 levels. China, struggling to find domestic home for its steel, is ramping up exports and destroying margins anywhere where it can. However, demand is struggling to pick up. US domestic steel output and prices have cracked despite imposition of heavy import duties. We believe we are heading for another almighty crash, and it is hard to see how Vesuvius can sustain H1/16 performance in H2/16. We expect FY EPS to come 7% below consensus.
Steel markets heading for another almighty crash
22 Jul 16
At the start of the year, we were wrong to assume that China would take action to curtail its excess capacity and help stabilise steel markets. Latest data suggests otherwise. As Chinese surplus and global imbalances build up, trade barriers in markets like the US and India will soon be overwhelmed. As production rates come under pressure outside China, it is hard to see how Vesuvius can sustain H1/16 performance in H2/16. Consequently, we are moving our recommendation from BUY to SELL, with a target price of 300p (from 380p).
Panmure Morning Note 13-06-2016
13 Jun 16
The economics of the US steel industry continue to improve, albeit not because of demand. Tariffs are helping to cut Chinese imports in the US markets, where steel prices are now up 70% since the low point in December 2015. More importantly, capacity utilisation at US steel mills has improved from 60% in December 2016 to 75% in early June. Year-to-date US steel output is still around 2% below the same period last year, better outcome than expected given the excess Chinese production. Bears will argue that fundamentally the industry is still weak given the global over-supply. We continue to believe that at some stage China will have to take action as its steel is increasingly unwelcome around the world.
Panmure Morning Note 09-05-2016
09 May 16
Vesuvius will issue a trading update on Thursday and we expect the management to remain cautious about trading, particularly given that China appears to be reversing its policy of cutting capacity. However, we continue to believe that the fundamentals of the steel industry are improving and therefore we maintain our BUY recommendation. We believe as its exports are made increasingly unwelcome across the world, China will have no option but to cut capacity as domestic stocks rise and losses mount. US steel prices are up more than 50% and this matters more to Vesuvius as US mills increase production and restocks on consumables. The management is not relying on a turnaround to deliver cash returns. However, as fundamentals improve the risk to our forecasts are on the upside. In the meantime, an attractive yield of 5%, which we believe is sustainable, underpins the share price.
Panmure Morning Note 23-03-2016
23 Mar 16
Improvement in steel markets look real; production is being cut. In the first two months of 2016, global steel output fell by over 5% year-on-year. China, which still produces 50% of world steel, is leading the way with 6% cut in output. In the US, after heavy falls in January, output grew 3% in February and has continued to grow at this pace in March so far. For Vesuvius, the mix of cuts is beneficial as it sells more and makes higher margins in the US than in China. We now believe US sales will fall by 5% this year versus our previous expectation of a 10% fall. At the same time, we expect Asia-Pacific sales to fall 5% and not 1%. However, the margin mix will improve, and as a result we are upgrading our 2016 forecast by 6% to 23.9p, and our target price to 380p (from 370p).
N+1 Singer - Morning Song 21-03-2017
21 Mar 17
accesso Technology (ACSO LN) Full year results in line, but key trading months still ahead | Augean (AUG LN) Double digit growth in ’16, good start to ‘17 | Earthport (EPO LN) Interims show continued top line strength | Goals Soccer Centres (GOAL LN) Good momentum under new team. It’s now all about delivery | IQE (IQE LN) FY’16 results prompt further upgrades | Microsaic Systems (MSYS LN) Challenges in 2016, strategy remains in place | mporium Group (MPM LN) Funds raised to help execute strategy | RhythmOne (RTHM LN) Dawn of the independents | ScS Group (SCS LN) Strong progress on key growth initiatives albeit comps now toughen | Sinclair Pharma (SPH LN) FY results: EBITDA ahead, Instalift™ gaining pace | Vectura Group (VEC LN) FY (9-month) results
N+1 Singer - Augean - Double digit growth in ’16, good start to ‘17
21 Mar 17
Augean reported another year of double digit growth for 2016, with profits in line with our forecasts. Sales grew by 21% excluding landfill tax, while adjusted PBT grew by 18% to £7.1m before amortisation of acquired intangibles. DPS was increased by 54% to 1.0p, 25% ahead of our estimate. The business units made further strategic progress, with revenues from their top 20 customers increasing from 42% to 43% of the total, of which 88% was under contract or a framework agreement, increasing forward visibility. There has been an encouraging start to 2017 and management is confident of delivering another year of profits growth. The shares trade on undemanding single digit multiples, offering good value.